Wow I’m gobsmacked by the spread
Me too!Wow I’m gobsmacked by the spread
my bolding and paragraph break.Abstract
Fibromyalgia (FM), one of the chronic widespread pain syndromes, and chronic fatigue syndrome (CFS) are important and common conditions. They are considered together here because they are commonly comorbid and because of their similarities—they are long-term conditions with a relatively poor prognosis; central nervous system mechanisms and deconditioning play an important role in aetiology; graded exercise and psychological treatments have an important role in management; and comorbid mental disorders are common and have an adverse impact on important outcomes, including disability and chronicity.
The prevalence of FM is rising, while that of CFS is declining. There is increased acceptance of the pivotal role of central nervous system factors in FM, while in CFS, the positions of different aetiological ‘movements’ appear bitterly entrenched. The main focus of this chapter is on FM and, in particular, key aspects of aetiology and treatment, especially those relating to the central nervous system.
This is why they're not retracting it. This is good for Cochrane, at least for now. It's terrible for patients, but it's good for the organization, and clearly this is all they care about.However, the flawed 2019 update remains active in the Cochrane Library and has been, according to Google Scholar (see https://scholar.google.com/scholar?hl=en&as_sdt=2005&sciodt=0,5&cites=12684092258614883664&scipsc= ), cited 839 times in other scientific papers, including by many articles that in turn have been cited over 1000 times. This includes some 49 articles so far this year, many of which relate to Long Covid. The flawed 2019 review has directly and indirectly impacted on hundreds of thousands of papers world wide.
Wow, a great (well, terrible, but useful) bit of information. Thanks Peter.However, the flawed 2019 update remains active in the Cochrane Library and has been, according to Google Scholar (see https://scholar.google.com/scholar?hl=en&as_sdt=2005&sciodt=0,5&cites=12684092258614883664&scipsc= ), cited 839 times in other scientific papers, including by many articles that in turn have been cited over 1000 times. This includes some 49 articles so far this year, many of which relate to Long Covid. The flawed 2019 review has directly and indirectly impacted on hundreds of thousands of papers world wide.
I'd be surprised if the number of citations is a major reason for Cochrane to retain it. Rather I think it's the fervent belief of people with influence inside Cochrane that the Exercise Review is correct that is a main driver. And maybe some funding is contingent (probably not formally) on the review staying there.This is why they're not retracting it. This is good for Cochrane, at least for now. It's terrible for patients, but it's good for the organization, and clearly this is all they care about.
I agree. The model of Cochrane is fundamentally flawed. Relying on people who are motivated to write a review, people who Cochrane does not pay, results in deeply biased reviews. NICE and the CDC still get things wrong, but at least there is the possibility of accountability.They're OK with this, this is who they are and what so-called evidence-based medicine is ultimately about: influence. They are, for all intents and purposes, influencers. Just like on TikTok, but with a lot more power. And, somehow, less accountability. The more they influence, the better they do.
I'd be surprised if the number of citations is a major reason for Cochrane to retain it. Rather I think it's the fervent belief of people with influence inside Cochrane that the Exercise Review is correct that is a main driver. And maybe some funding is contingent (probably not formally) on the review staying there.
I had been surprised by the extent and reach of the citations, and this not only illustrates how these ideas have unjustified creep into other conditions but also illustrates how deeply engrained they have become in the post viral conditions literature. For me this strengthens how vitally important it is we continue to fight for the withdrawal of the deeply flawed exercise review, however, for what it is worth, I agree with @Hutan that Cochrane’s current intransigence relates not primarily to loss of their own reputation, as their current shenanigans are likely to ultimately cause greater reputational damage than withdrawal of a single review would trigger.
Rather I also suspect that a number of individuals within or connected to Cochrane are fighting for the preservation of exercise therapy as a preferred intervention and for their personal reputations, without regard for the damage this is causing to Cochrane. I feel it is similar to the backlash trying to block the final publication of the NICE guidelines that was undertaken without any concern about undermining the status of the NICE guidelines process.
Is there any way of seeing how many of the citations are from people who were part of the review itself ie self-citations even if they are part of a different 'group' on each occasion?
It's hard to reconcile that with what Cochrane's leadership is doing, especially the editor-in-chief. They only have the organization's reputation at stake there, they are not personally involved in the outcome of this particular review or research.Rather I also suspect that a number of individuals within or connected to Cochrane are fighting for the preservation of exercise therapy as a preferred intervention and for their personal reputations, without regard for the damage this is causing to Cochrane. I feel it is similar to the backlash trying to block the final publication of the NICE guidelines that was undertaken without any concern about undermining the status of the NICE guidelines process.